Ende Eric J is a director of Matinas Biopharma Holdings Inc.
Person profile
Roles
Matinas Biopharma
Director
Avadel Pharmaceuticals
Director
Address
Bedminster, New Jersey
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Matinas BioPharma Holdings, Inc.
3 Nov 23
4
AVADEL PHARMACEUTICALS PLC
3 Aug 23
4
AVADEL PHARMACEUTICALS PLC
19 May 23
4
AVADEL PHARMACEUTICALS PLC
23 Nov 22
4
Matinas BioPharma Holdings, Inc.
16 Nov 22
4
NeuBase Therapeutics, Inc.
12 Sep 22
4
AVADEL PHARMACEUTICALS PLC
5 Aug 22
4
AVADEL PHARMACEUTICALS PLC
1 Jun 22
4
AVADEL PHARMACEUTICALS PLC
31 May 22
4
NeuBase Therapeutics, Inc.
5 Jan 22
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
1 Nov 23 | MTNB Matinas Biopharma | Stock option Common Stock | Grant | Acquire A | No | No | 0.2088 | 437,244 | 91.30 k | 437,244 |
1 Aug 23 | AVDL Avadel Pharmaceuticals | Stock Option ADSs | Grant | Acquire A | No | No | 14.1 | 33,000 | 465.30 k | 33,000 |
18 May 23 | AVDL Avadel Pharmaceuticals | ADSs | Buy | Acquire P | No | No | 13.9308 | 13,000 | 181.10 k | 167,900 |
22 Nov 22 | AVDL Avadel Pharmaceuticals | ADSs | Buy | Acquire P | No | No | 7.8025 | 20,000 | 156.05 k | 154,900 |
14 Nov 22 | MTNB Matinas Biopharma | Stock option Common Stock | Grant | Acquire A | No | No | 0.7268 | 142,657 | 103.68 k | 142,657 |